Moderna, Inc. Common Stock
MRNA •
Sell Open
Signal type
Sell
Status
Open
Open Price
$47.14
Stop Loss
$54.03
Performance
-12.09%
Days Open
16
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 30, 2026
Open Price $47.14
Stop Loss $54.03
Timespan Day
Company Profile
Name Moderna, Inc. Common Stock
Ticker MRNA
Market Cap $11.71B
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $52.84
List Date Dec 7, 2018
Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Website Open Company Website